|
Q1 FY2027
As of Aug 1, 2026
|
Q4 FY2026
As of May 2, 2026
|
Q3 FY2026
As of Jan 31, 2026
|
Q2 FY2026
As of Nov 1, 2025
|
Q1 FY2026
As of Aug 2, 2025
|
Q4 FY2025
As of May 3, 2025
|
Q3 FY2025
As of Feb 1, 2025
|
Q2 FY2025
As of Nov 2, 2024
|
Q1 FY2025
As of Aug 3, 2024
|
Q4 FY2024
As of Apr 27, 2024
|
Q3 FY2024
As of Jan 27, 2024
|
Q2 FY2024
As of Oct 28, 2023
|
Q1 FY2024
As of Jul 29, 2023
|
Q4 FY2023
As of Apr 29, 2023
|
Q3 FY2023
As of Jan 28, 2023
|
Q2 FY2023
As of Oct 29, 2022
|
Q1 FY2023
As of Jul 30, 2022
|
Q4 FY2022
As of Apr 30, 2022
|
Q3 FY2022
As of Jan 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Contract assets | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Right-of-use assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Shareholders' Equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued compensation and benefits | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Other current liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Non-current operating lease liabilities | |||||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders' equity: | |||||||||||||||||||
| Convertible preferred shares, $0.00005 par value; 50,000 shares authorized; no shares issued and outstanding at April 29, 2023 and April 30, 2022 | |||||||||||||||||||
| Ordinary shares, $0.00005 par value; 1,000,000 shares authorized; 187,768 and 185,419 shares issued and outstanding at August 1, 2026 and May 2, 2026, respectively | |||||||||||||||||||
| Additional paid in capital | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Total shareholders' equity | |||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
